April 2015 FDA Recall Kabiven by Fresenius Kabi Usa, Llc
D-1114-2015 - Labeling

This Class II drug recall was voluntarily initiated by Fresenius Kabi Usa, Llc on April 28, 2015 for the product Kabiven. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1114-2015

Reason for Recall
Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids
Initiated
04-28-2015
Reported
06-10-2015
Quantity
5,488 Bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fresenius Kabi USA, LLC
US; Nationwide, including Puerto Rico
KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free], Rx Only. Manufactured by: FRESENIUS KABI Uppsala, Sweden. Packaged in 1) 1,540 mL Bags, NDC: 63323-712-15, and 2) 2,053 mL Bags, NDC: 63323-712-20.

Batch or Lot Expiration Information

Lot# 1)
Lot# 10HH8781, Expiry: 07-2016; 2)
Lot# 10HH8739, Expiry: 07-2016.